There are 2789 resources available
Mechanisms of resistance
Presenter: Piro Lito
Session: Targeting KRAS in lung cancer: Progress and next steps
Resources:
Slides
Webcast
All things KRAS not G12C
Presenter: Chiara Ambrogio
Session: Targeting KRAS in lung cancer: Progress and next steps
Resources:
Slides
Webcast
Combinations including KRAS inhibitors
Presenter: Natasha Leighl
Session: Targeting KRAS in lung cancer: Progress and next steps
Resources:
Slides
Webcast
Introdcution
Presenter: Javier Martin Broto
Session: Exploring avenues for immunotherapy in sarcoma
Resources:
Slides
Webcast
Tumor microenvironment and predictive biomarkers for IO treatment in sarcomas
Presenter: Hans-Ulrich Schildhaus
Session: Exploring avenues for immunotherapy in sarcoma
Resources:
Slides
Webcast
PD-1 checkpoint inhibitors in sarcoma: Evidence and future indications
Presenter: Sandra D'Angelo
Session: Exploring avenues for immunotherapy in sarcoma
Resources:
Slides
Webcast
Introduction
Presenter: Michael Thomas
Session: Neoadjuvant immunotherapy of NSCLC
Resources:
Slides
Webcast
What is the optimal systemic therapy? IO-mono, IO-IO, IO-chemo
Presenter: Patrick Forde
Session: Neoadjuvant immunotherapy of NSCLC
Resources:
Slides
Webcast
Surgical considerations
Presenter: Giulia Veronesi
Session: Neoadjuvant immunotherapy of NSCLC
Resources:
Slides
Webcast
Pathology & biomarker considerations
Presenter: Keith Kerr
Session: Neoadjuvant immunotherapy of NSCLC
Resources:
Slides
Webcast